Zalutumumab

Word ZALUTUMUMAB
Character 11
Hyphenation N/A
Pronunciations N/A

Definitions and meanings of "Zalutumumab"

What do we mean by zalutumumab?

Here you will find one or more explanations in English for the word zalutumumab. Define zalutumumab, zalutumumab synonyms, zalutumumab pronunciation, zalutumumab translation, English dictionary definition of zalutumumab.

Synonyms and Antonyms for Zalutumumab

  • Synonyms for zalutumumab
  • Zalutumumab synonyms not found!!!
  • Antonyms for zalutumumab
  • Zalutumumab antonyms not found!

The word "zalutumumab" in example sentences

Genmab shares slumped 20.4% in Copenhagen after the Danish drug maker said that top-line results from a zalutumumab Phase III study in patients with recurrent or metastatic squamous cell carcinoma of the head and neck who failed standard platinum-based chemotherapy didn't meet its primary endpoint of demonstrating a statistically significant difference in overall survival. ❋ Ishaq Siddiqi (2010)

Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combinatio ... ❋ Editors (2010)

In March, we announced top-line results from a zalutumumab Phase III study in refractory head and neck chemotherapy. ❋ Unknown (2010)

The maintenance dose will be adjusted as necessary until the patient develops a dose limiting skin rash, up to a maximum dose of 16 mg / kg of zalutumumab. ❋ Unknown (2009)

COPENHAGEN, Denmark, Jan. 5, 2009 (GLOBE NEWSWIRE) -- Genmab A / S (OMX: GEN) announced today that the interim survival analysis of the Phase III pivotal study investigating zalutumumab ❋ Unknown (2009)

Patients in the study will be randomized into two treatment groups: zalutumumab in combination with best supportive care or best supportive care alone. ❋ Unknown (2009)

The objective of the study is to evaluate the efficacy of zalutumumab incombination with best supportive care as compared to best supportive care alone in terms of overall survival. ❋ Unknown (2009)

For zalutumumab: The FDA placed a partial clinical hold on zalutumumab clinical studies being conducted under the US Investigational New Drug (IND) application, as well as requests for new studies in June 2009. ❋ Unknown (2009)

An Independent Data Monitoring Committee (IDMC) has evaluated the interimresults and concluded that the benefit-risk profile of zalutumumab isacceptable. ❋ Unknown (2009)

Patients treated with zalutumumab in combination with best supportive care will receive an initial dose of 8mg / kg of zalutumumab, followed by weekly infusions of a maintenance dose until disease progression. ❋ Unknown (2009)

Cross Reference for Zalutumumab

  • Zalutumumab cross reference not found!

What does zalutumumab mean?

Best Free Book Reviews
Book Name Author
Dark Psychology and Manipulati... E-Book Margaret Morrison
1984 E-Book George Orwell
Friend Zone E-Book Camilla Isley
A Viking's Shadow E-Book H L Marsay
Her Warrior King E-Book Michelle Willingham
Best IOS App Reviews
App Name Developer
Cash App App Reviews Block, Inc.
McDonald's App Reviews McDonald's USA
Google Maps App Reviews Google LLC
Amazon Shopping App Reviews AMZN Mobile LLC
SHEIN - Shopping Online App Reviews ROADGET BUSINESS PTE. LTD.